StonvexLoading…
StonvexStonvexStonvexCore line items from NORD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Q4 2024 2024-12-31 | Q3 2024 2024-09-30 | Annual 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $5.00K | $5.00K | $2.50K | $2.50K |
Operating Income | $-2.92M | $-2.03M | $-765.56K | $-307.59K |
Net Income | $-2.90M | $-2.29M | $-758.95K | $-298.20K |
EPS (Diluted) | $-0.32 | $-0.35 | $-0.19 | $-0.29 |
Total Assets | $70.25M | $59.72M | $20.79M | $1.81M |
Total Liabilities | $10.38M | $888.87K | $152.87K | $26.41K |
Cash & Equivalents | $19.91K | $28.00K | $46.13K | $49.93K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 17.25M | 17.20M | 4.97M | 1.11M |